HBM Healthcare Investments (Cayman) Ltd. 13D and 13G filings for IO Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 4:15 pm Purchase |
2023-12-31 | 13G | IO Biotech, Inc. IOBT |
HBM Healthcare Investments (Cayman) Ltd. | 5,523,439 8.200% |
1,578,947 (+40.03%) |
Filing |
| 2024-02-13 4:06 pm Sale |
2023-12-31 | 13G | IO Biotech, Inc. IOBT |
HBM Healthcare Investments (Cayman) Ltd. | 3,944,492 6.000% |
-1,578,947 (-28.59%) |
Filing |
| 2023-08-15 3:15 pm Purchase |
2023-08-09 | 13G | IO Biotech, Inc. IOBT |
HBM Healthcare Investments (Cayman) Ltd. | 5,523,439 8.190% |
1,524,008 (+38.11%) |
Filing |
| 2023-08-14 3:45 pm Purchase |
2023-08-09 | 13G | IO Biotech, Inc. IOBT |
HBM Healthcare Investments (Cayman) Ltd. | 3,999,431 6.100% |
1,578,947 (+65.23%) |
Filing |
| 2022-02-11 4:02 pm Purchase |
2021-12-31 | 13G | IO Biotech, Inc. IOBT |
HBM Healthcare Investments (Cayman) Ltd. | 2,420,484 8.400% |
2,420,484 (New Position) |
Filing |